iXpressGenes, Inc.
Biotechnology company · Huntsville, Alabama, United States
iXpressGenes, Inc. is a biotechnology company headquartered in Huntsville, Alabama, United States. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $2.4 million sold in a notice filed in 2025.
iXpressGenes at a glance
What does iXpressGenes do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2008 to 2016). NIH funding came from the National Institute of General Medical Sciences.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.4 million sold (2025).
Frequently asked questions about iXpressGenes
Where is iXpressGenes headquartered?
iXpressGenes, Inc. is headquartered in Huntsville, Alabama, United States.
What does iXpressGenes do?
iXpressGenes, Inc. is a biotechnology company.
Similar companies
- CFD Research CorporationHuntsville, Alabama, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences